In February 2020, AffinityImmuno responded quickly to the COVID19 pandemic by performing immunizations to generate research antibodies. We have developed antibodies to the full length spike protein and the two subunits (S1 and S2).
Our standard polyclonal chicken egg IgY antibody service is a 35 day immunization program, followed by 14 days of egg collection with the flexibility to continue IgY production thereafter.
AffinityImmuno Inc. was one of eight semi-finalists that presented at the BIC pitch competition on November 3 and made it to the final round on November 4.
It was a great opportunity to showcase the work we have done in the battle against the COVID19 pandemic, particularly in the development of our SARS-CoV-2 spike protein-ligand binding assay (surrogate Virus Neutralization Test).
Check out our articles in The Guardian and the CBC.
Subscribe to receive product updates & promotions.